DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,270,439 | -1.4% | 45,427 | -4.6% | 1.37% | -2.6% |
| Q2 2023 | $11,424,960 | +9.4% | 47,604 | +14.9% | 1.41% | +3.7% |
| Q1 2023 | $10,442,521 | -7.7% | 41,432 | -2.8% | 1.36% | -12.5% |
| Q4 2022 | $11,314,855 | -0.3% | 42,630 | -3.0% | 1.55% | -4.4% |
| Q3 2022 | $11,351,000 | -4.2% | 43,946 | -6.0% | 1.62% | +6.9% |
| Q2 2022 | $11,852,000 | -19.0% | 46,750 | -6.3% | 1.52% | -1.0% |
| Q1 2022 | $14,635,000 | -12.5% | 49,891 | -9.2% | 1.53% | -9.6% |
| Q3 2021 | $16,729,000 | -25.3% | 54,949 | -34.1% | 1.70% | -12.3% |
| Q2 2021 | $22,381,000 | +11.0% | 83,399 | -6.9% | 1.93% | +19.1% |
| Q1 2021 | $20,160,000 | -6.8% | 89,567 | -8.0% | 1.62% | +0.7% |
| Q4 2020 | $21,627,000 | +1.2% | 97,357 | -1.9% | 1.61% | -5.0% |
| Q3 2020 | $21,381,000 | +2.6% | 99,293 | -15.7% | 1.70% | +9.1% |
| Q2 2020 | $20,831,000 | +26.3% | 117,803 | -1.1% | 1.56% | +5.4% |
| Q1 2020 | $16,491,000 | -8.2% | 119,149 | +1.8% | 1.48% | +8.9% |
| Q4 2019 | $17,962,000 | +1.2% | 117,033 | -4.8% | 1.36% | -1.7% |
| Q3 2019 | $17,756,000 | -48.6% | 122,938 | -49.1% | 1.38% | -8.6% |
| Q2 2019 | $34,546,000 | +6.7% | 241,716 | -1.4% | 1.51% | +4.4% |
| Q1 2019 | $32,373,000 | +26.0% | 245,214 | -1.6% | 1.44% | +11.4% |
| Q4 2018 | $25,699,000 | -7.4% | 249,212 | -2.4% | 1.30% | +9.7% |
| Q3 2018 | $27,749,000 | +31.7% | 255,375 | +19.6% | 1.18% | +25.5% |
| Q2 2018 | $21,072,000 | +5.3% | 213,536 | +4.5% | 0.94% | -1.8% |
| Q1 2018 | $20,003,000 | +1.1% | 204,304 | -4.2% | 0.96% | +5.7% |
| Q4 2017 | $19,795,000 | -29.3% | 213,265 | -34.7% | 0.91% | -33.7% |
| Q3 2017 | $28,008,000 | -30.7% | 326,514 | -31.8% | 1.37% | -25.4% |
| Q2 2017 | $40,411,000 | -2.6% | 478,864 | -1.3% | 1.83% | -3.1% |
| Q1 2017 | $41,490,000 | +3.6% | 485,094 | -5.7% | 1.89% | +1.1% |
| Q4 2016 | $40,044,000 | +4.9% | 514,437 | +5.6% | 1.87% | +5.2% |
| Q3 2016 | $38,181,000 | -24.6% | 487,067 | -2.8% | 1.78% | -24.7% |
| Q2 2016 | $50,624,000 | +0.1% | 501,224 | -6.0% | 2.36% | +1.1% |
| Q1 2016 | $50,583,000 | +0.3% | 533,234 | -1.8% | 2.34% | -1.4% |
| Q4 2015 | $50,437,000 | +15.2% | 543,034 | +5.7% | 2.37% | +10.2% |
| Q3 2015 | $43,784,000 | -1.3% | 513,834 | -0.9% | 2.15% | +6.3% |
| Q2 2015 | $44,367,000 | +2.9% | 518,364 | +2.1% | 2.02% | +2.1% |
| Q1 2015 | $43,104,000 | -2.9% | 507,703 | -2.0% | 1.98% | -4.0% |
| Q4 2014 | $44,410,000 | +27.4% | 518,143 | +13.0% | 2.06% | +1.5% |
| Q3 2014 | $34,849,000 | -5.2% | 458,660 | -1.8% | 2.03% | -5.5% |
| Q2 2014 | $36,775,000 | +5.9% | 467,100 | +0.9% | 2.15% | +2.1% |
| Q1 2014 | $34,733,000 | -5.9% | 463,110 | -3.2% | 2.11% | -4.4% |
| Q4 2013 | $36,924,000 | +15.6% | 478,290 | +3.8% | 2.20% | -1.4% |
| Q3 2013 | $31,946,000 | +6.8% | 460,842 | -2.5% | 2.23% | +4.3% |
| Q2 2013 | $29,923,000 | – | 472,712 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |